HIGHLIGHTS
- who: Bax et al. from the Department of Medicine, Qingdao University, Qingdao, Department of Oncology, Jining No, People`s Hospital, Jining, Cancer Center, Peking University International Hospital, Beijing, PR China have published the research work: Tropical Journal of Pharmaceutical Research July 2018; 17 (7): 1271-1277, in the Journal: (JOURNAL)
- what: The aim of this study was to investigate the effect of DHF on the proliferation of human hepatoma HepG2 cells, and the likely underlying mechanism. The findings of this investigation demonstrate that DHF suppresses the proliferative capacity of HepG2 cells in_vitro and in_vivo via . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.